Skip to main content
Back to News
BioticsAI has received FDA clearance for its AI software designed to detect fetal abnormalities, fol...
Product
1 min read
US

BioticsAI has received FDA clearance for its AI software designed to detect fetal abnormalities, fol...

The AMW Read

This is an incremental update for a player in the Vertical AI Healthcare segment, marking a transition from concept to regulated medical device through FDA clearance.
NoveltySignificance
Healthcare & Bio Β· Player Map

BioticsAI has received FDA clearance for its AI software designed to detect fetal abnormalities, following a 3-year validation process. The tool, trained on hundreds of thousands of diverse ultrasounds, ensures anatomical completeness to reduce misdiagnosis in the US. This milestone transitions the platform from an award-winning concept to a regulated medical device addressing maternal health disparities. Scaling across national health systems is now the priority to improve outcomes. πŸ₯πŸ‘Ά

#AI #MedTech #FDA #HealthTech

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 5d agoAnthropic releases Claude Science Beta, a multi-agent AI workbench designed to run end-to-end resear...Anthropic
  2. 6d agoBaiyao Tech (η™Ύζ›œη§‘ζŠ€) releases AURA CellOS, first AI virtual cell based on LLM-JEPA architecture.η™Ύζ›œη§‘ζŠ€
  3. 1w agoAnthropic wants to develop its own drugs. At an event called β€œThe Briefing: AI for Science,” the com...Anthropic
  4. 1w agoAnthropic launches Claude Science AI workbench for life sciences researchAnthropic
  5. 5mo agoBioticsAI has received FDA clearance for its AI software designed to detect fetal abnormalities, fol... Β· THIS ARTICLE

More news from BioticsAI

Stay updated with the latest news and announcements from BioticsAI.

View all BioticsAI news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard